DeepMPS: Development and validation of a deep learning model for whole slide image base prognostic prediction of low grade Lung adenocarcinoma patients
Authors: Jagajampi Akshay , Khadirnaikar Seema , Malik Prabhat S , Jain Deepali , Naveen MB , Shukla Sudhanshu K 
Published: December 2022

AbstractLung adenocarcinoma (LUAD) is one of the most common cancers, and patients’ prognostication is crucial for treatment decisions. Histopathological images are the most generally accessible clinical information, however they have not been employed in clinical settings for prognosis.In this study, we used WSIs and clinical data from TCGA (training and testing) and East Asian Cohort (EAS, Validation) to develop and validate DL-based prognosticator. To circumvent the need for manual ROI generation, WSIs from these patients were divided into smaller patches and scored. DeepMPS prediction model was built using the top scoring 226,383 patches. The DeepMPS model showed a C-index of 0.638 in the TCGA training cohort. The univariate and multivariate cox regression analysis identified DeepMPS as an independent predictor of survival (HR: 9.48, p-value: <0.0001) in the training cohort. The training cohort of patients was separated into low and high-risk groups at various points. Kaplan-Meier analysis showed the highest difference in survival of low and high-risk patients at the 75th percentile (HR: 3.58, 95% CI: 2.57-5.00, p-value: <0.0001). At the same cut-off as the training samples, TCGA testing cohort patients demonstrated a significant difference in survival when split into low and high-risk patients (HR: 2.30, 95% CI: 1.11-4.82, p-value: 0.044). The DeepMPS model was validated in the EAS cohort patients. DeepMPS risk score significantly segregated EAS patients into low and high-risk groups at the same cut-off point as the training cohort (HR: 2.09, 95% CI: 1.11-3.97, p-value: 0.008). In multivariate Cox regression analysis, the DeepMPS score outperformed the stage in survival prediction. We also compared the DeepMPS model with the previously developed DL-based model to show that it was the best predictor of survival with the highest C-index. In conclusion, we developed a robust DL-based prognostic model which can predict the LUAD outcome without manual intervention using histopathological images.Author SummaryRight from the initial step of cancer diagnosis, histopathological images are the widely relied source of information for therapeutic decision making. Though these images carry a substantial amount of information, their use remains restricted to determining the grade of the tumor by pathologists. The advent of computational techniques has given rise to the ability to capture vital information besides the grade of the tumor, which humans might not be able to quantify visually. To this end, this work proposes a deep learning based model, Deep Multi-Modal Prognosis System (DeepMPS), to predict the prognosis of the patients based on the histopathological images to provide additional information to the pathologist which will aid in clinical decision making. DeepMPS predicts a risk score associated with each individual based on histopathological images and clinical factors. The risk score obtained from the proposed system is an independent predictor of survival. As the proposed system is independent of the manual region-of-interest (RoI) generation, it will ease the pathologist’s workload.